1.Effect of Pharmaceutical Care Program on Hypotension-A Meta Analysis
China Pharmacy 2005;0(17):-
OBJECTIVE:To evaluate the effect of pharmaceutical care (PC) program on hypotension. METHODS: The pertinent literature from January 1999 to February 2008 was retrieved from Medline, EMBASE, Cochrane, CNKI, CBM and other databases, and the randomized controlled trials (RCTs) with the intervention measures of PC were collected. The literature retrieving and screening were done respectively by 2 statistical clerks. A meta-analysis of the data was conducted by using the Review Manager 4.2 software. RESULTS: A total of 5 RCTs with 585 hypertension patients were included in this Meta analysis. Compared with the control group, the PC program intervention group had significantly lower systolic blood pressure (SBP) and diastolic blood pressure (DBP) after follow-up; and the SBP and DBP had a much better improvement in the intervention group than in the control group. CONCLUSION: The high blood pressure can be effectively controlled by carrying out the PC program such as medication consultation and health education etc in hypertensive patients.
2.Effects of TMB-8 on cerebral blood flow of focal cerebral ischemia in rats
Bin WANG ; Yongbing NI ; Minying ZHANG
Journal of Clinical Neurology 1995;0(04):-
Objective To study the effect of TMB 8 on cerebral blood flow(CBF) of focal cerebral ischemia in the rats.Methods CBF in the middle cerebral artery occlusion after the middle cerebral artery occlusion was measured by a Laser Doppler Flowmeter. TMB 8 was administered 30 min before occlusion and 20 min after occlusion respectively.Results CBF was reduced quickly. TMB 8 0.5,1,2 mg/kg was administered 30 min before occlusion of the middle cerebral artery.The dosage inhibited the reduction of CBF,20 min after occlusion, CBF was increased by TMB 8 1 mg/kg significantly.Conclusion TMB 8 could prevent and treat the reduction of CBF in focal cerebral ischemia of MCAO in the rats,and improved the supply of blood in ischemic area.
3.Operation Mode and Problems of TCM Decoction for Patients
Hao JIANG ; Zhenhua WU ; Yongbing NI
China Pharmacy 2015;26(31):4333-4335
OBJECTIVE:To provide new ideas for the supervision of TCM decoction for patients. METHODS:The mode of outsourced TCM decoction for patients in Nanjing and Hangzhou area were investigated and analyzed,especially their operation mode. The safety problems of quality of the mode were analyzed from the legitimacy and standardization. RESULTS & CONCLU-SIONS:The present problems include the mismatch of professional and technical personnel of TCM decoction pieces and their qua-lification requirements;the lack of communication of pharmacists and prescribers;no restrictions for outsourced decoction of toxic TCM decoction pieces for patients;the insufficient attention for the quality and safety of packaging materials;being difficult to im-plement the main responsibility of medical institutions,etc. It is suggested to establish the filing system of centralized TCM decoc-tion institution for patients;the stationed system of pharmacy technician in medical institutions;the training and evaluation system of dispensing,decocting and other stations;the regular inspection system of health and pharmaceutical administration department;the quality evaluation system of TCM decoction for patients by following up medical staff and patients. So that it can explore a new idea for monitoring ofclearing the powers of regulatory,full participation in medical institutions,standardization and management of pharmaceutical wholesale enterprises,active supervision by patients.
4.Pharmaceutical Care in Drugstores from the Perspective of Drug Administration
Yongbing NI ; Wenlong HUANG ; Yongfa CHEN
China Pharmacy 2005;0(13):-
OBJECTIVE: To explore approaches for further development of pharmaceutical care in retail drugstores by strengthening drug administration. METHODS: The main problems occurred in pharmaceutical care were analyzed from the perspective of drug administration. RESULTS & CONCLUSIONS: The main problems occurred in pharmaceutical care were the absence of laws and regulations related to pharmaceutical care,misalignment between the access criteria for retail pharmacy and the necessary conditions for pharmaceutical care. The development of pharmaceutical care could be promoted by perfecting current law system,enhancing the access criteria for running retail drugstore,and strengthening drug administration etc.
5.Derivatization of berberine based on its synergistic antifungal activity with fluconazole against fluconazole-resistant Candida albicans.
Shujuan TIAN ; Yue GAO ; Chengxu ZANG ; Zhan CAI ; Tingjunhong NI ; Shanlun TAN ; Yongbing CAO ; Yuanying JIANG ; Dazhi ZHANG
Acta Pharmaceutica Sinica 2014;49(11):1563-8
Abstract: Our previous work revealed berberine can significantly enhance the susceptibility of fluconazole against fluconazole-resistant Candida albicans, which suggested that berberine has synergistic antifungal activity with fluconazole. Preliminary SAR of berberine needs to be studied for the possibility of investigating its target and SAR, improving its drug-likeness, and exploring new scaffold. In this work, 13-substitutited benzyl berberine derivatives and N-benzyl isoquinoline analogues were synthesized and characterized by 1H NMR and MS. Their synergetic activity with fluconazole against fluconazole-resistant Candida albicans was evaluated in vitro. The 13-substitutited benzyl berberine derivatives 1a-1e exhibited comparable activity to berberine, which suggested that the introduction of functional groups to C-13 can maintain its activity. The N-benzyl isoquinolines, which were designed as analogues of berberine with its D ring opened, exhibited lower activity than berberine. However, compound 2b, 2c, and 4b showed moderate activity, which indicated that berberine may be deconstructed to new scaffold with synergistic antifungal activity with fluconazole. The results of our research may be helpful to the SAR studies on its other biological activities.
6.Legislative Suggestions on Improving Drug Quality Supervision of Medical Institutions in China
Yongfa CHEN ; Yingying GE ; Yongbing NI
China Pharmacy 2018;29(1):1-4
OBJECTIVE:To provide reference and basis for strengthening the drug quality supervision of medical institutions.METHODS:The problems about the drug quality supervision of the medical institutions were analyzed from the angle of legislation.Countermeasures for strengthening drug quality supervision of medical institutions in China as well as legislative suggestions on improving drug quality supervision of medical institutions in China were put forward.RESULTS & CONCLUSIONS:At present,the existing problems about drug quality supervision in medical institutions include that pharmacy setting lack mandatory standards;routine drug quality supervision is mainly the formal regulation;the punishment of drug related illegal behavior in medical institutions is too light,etc.To strengthen drug quality supervision of medical institutions in China,it is suggested that the government should establish the mandatory standards for medical institution pharmacy setting,add administrative inspections,and formulate Good Using Practice applicable to the whole country.When perfecting the law of drug quality supervision in medical institutions in China,relevant provisions may be added in The Drug Administration Law of the PRC,Regulations for the Implementation of Drug Administration Law,and the subordinate laws and regulations of Management Regulation of Medical Institutions so as to strengthen drug quality supervision of medical institutions.